CODX vs UPST · rev $3.9M vs P/E 74, rev $636.5M
Co-Diagnostics, Inc. Common Stock (CODX) versus Upstart Holdings Inc (UPST) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Upstart Holdings Inc (UPST) is a credit services company listed on NASDAQ.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported UPST revenue for 2024-12-31 was $636.5M. Net income was -$128.6M. Revenue was up 23.9% from 2023-12-31 to 2024-12-31. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
CODX currently screens at market cap $31.4M. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
Not investment advice. Open the CODX and UPST stock pages for the full models.
Not investment advice.